Page 10 - Neuronetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday s Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ:LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE:ABBV) an.

United statesPaul hoelscherTim walbertLandos biopharmaChuck jehlBrainstorm cell therapeutics incPharma limitedLending corporationInvivyd incThird circuit courtLucid group incSagimet biosciences incAbbvie incMasimo corporationLaser photonics corporationBitcoin depot inc

30,208 Shares in Neuronetics, Inc (NASDAQ:STIM) Purchased by FNY Investment Advisers LLC

30,208 Shares in Neuronetics, Inc (NASDAQ:STIM) Purchased by FNY Investment Advisers LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam andrew macanKeithj sullivanPiper sandlerCubist systematic strategiesExchange commissionInvestment advisersFny investment advisersNeuronetics company profileAmerica corpNeuronetics incSecurities exchange commissionFree reportSigma investmentsSystematic strategiesState street corp

Insider Selling: Neuronetics, Inc (NASDAQ:STIM) CEO Sells $67,348 73 in Stock

Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) CEO Keith J. Sullivan sold 20,851 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $3.23, for a total value of $67,348.73. Following the completion of the transaction, the chief executive officer now directly […]

United statesKeithj sullivanNeuronetics company profileSecurities exchange commissionNeuronetics incWolverine tradingWorth venture partnersTower research capitalAlgert globalGet free reportExchange commissionVenture partnersResearch capitalNeurostar advanced therapy systemNeuronetics dailyNasdaq stim

Neuronetics, Inc (NASDAQ:STIM) CEO Sells $70,915 68 in Stock

Neuronetics, Inc (NASDAQ:STIM) CEO Sells $70,915 68 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesKeithj sullivanKent lake capitalCannell capitalSilvercrest asset management groupNeuronetics incVanguard group incGet free reportLake capitalAsset management groupNeurostar advanced therapy systemNeuronetics daily

GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing.

United statesBenjamin kleinUs securities exchangeCompany commonExchange commissionNeuronetics incListing qualifications departmentNasdaq stock marketNasdaq listing ruleCommon sharesExchange actTranscranial magnetic stimulationMajor depressive disorderMadryn asset managementRestructuring planGreenbrook tms inc